 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Equioxx, Previcox |
| AHFS/Drugs.com | |
| License data | |
| Routes of administration | By mouth |
| ATCvet code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H20O5S |
| Molar mass | 336.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Firocoxib, sold under the brand namesEquioxx andPrevicox among others, is anonsteroidal anti-inflammatory drug of theCOX-2 inhibitor (coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox).[2][4][9] Firocoxib was the first COX-2 inhibitor approved by the U.S.Food and Drug Administration for horses.[10] Firocoxib is not intended or approved for use in human medicine.[2][4][5][6][11]
Firocoxib, manufactured by Merial, was approved for veterinary use in the United States for dogs in July 2004,[12] and for horses in July 2007, as an oral paste (Equioxx) and July 2016, as tablets.[13][14]
Firocoxib is also available as ageneric medication for horses[14] and for dogs.[12]
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key:underline indicates initially developed first-in-class compound of specific group;#WHO-Essential Medicines;†withdrawn drugs;‡veterinary use. | |
